Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

NCT07111494 · PHASE4 · RECRUITING · Sponsor: Medical College of Wisconsin · Conditions: Psoriatic Arthritis

By Priya Raman · Science Reporter

Nov 5 07:00 ETSource: ClinicalTrials.gov

From the source

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
NCT07111494 · PHASE4 · RECRUITING · Sponsor: Medical College of Wisconsin · Conditions: Psoriatic Arthritis (PsA).

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT07111494